The Nicorette product is being manufactured and packaged by Cambrex Zenara in its Hyderabad, India facility.
Cambrex president and CEO Steven Klosk said that Nicotine Replacement Therapeutics represent an important part of their product portfolio.
Cambrex Zenara president Ashok Narasimhan said that being selected by Johnson & Johnson as their manufacturing partner is a testament to Cambrex Zenara’s ability to supply.
"This demonstrates our commitment to provide affordable solutions for smoking cessation," Narasimhan said.